Literature DB >> 21779472

The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.

Laurent Pangon1, Nicholas D Sigglekow, Mark Larance, Sam Al-Sohaily, Dessislava N Mladenova, Christina I Selinger, Elizabeth A Musgrove, Maija R J Kohonen-Corish.   

Abstract

MCC is a potential tumor suppressor gene, which is silenced by promoter hypermethylation in a subset of colorectal cancers. However, its functions have remained poorly understood. In the present study, we describe a novel function of MCC in the DNA damage response. Several novel phosphorylation sites were identified by mass spectrometry, including 2 highly conserved ATM/ATR consensus sites at serine 118 and serine 120. In addition, exposure to ultraviolet radiation (UV), but not phleomycin, caused PI3K-dependent phosphorylation of MCC and its nuclear localization. Re-expression of MCC in HCT15 colorectal cancer cells led to a G2/M arrest, and MCC knockdown impaired the induction of a G2/M arrest following UV radiation. Finally, mutation of S118/120 to alanine did not affect MCC nuclear shuttling following UV but did impair MCC G2/M checkpoint activity. Thus, these results suggest that MCC is a novel target of the DNA damage checkpoint and that MCC is required for the complete cell cycle arrest in the G2/M phase in response to UV.

Entities:  

Keywords:  DNA damage response; G2/M checkpoint; colorectal cancer; phosphorylation

Year:  2010        PMID: 21779472      PMCID: PMC3092258          DOI: 10.1177/1947601910388937

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  31 in total

Review 1.  DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?

Authors:  D Durocher; S P Jackson
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

2.  Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs.

Authors:  John C Obenauer; Lewis C Cantley; Michael B Yaffe
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Localization of MCC (mutated in colorectal cancer) in various tissues of mice and its involvement in cell differentiation.

Authors:  T Senda; A Matsumine; H Yanai; T Akiyama
Journal:  J Histochem Cytochem       Date:  1999-09       Impact factor: 2.479

4.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Substrate specificities and identification of putative substrates of ATM kinase family members.

Authors:  S T Kim; D S Lim; C E Canman; M B Kastan
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

6.  Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis.

Authors:  David Olmeda; Susanna Castel; Senén Vilaró; Amparo Cano
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

7.  DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1.

Authors:  Oscar Fernandez-Capetillo; Hua-Tang Chen; Arkady Celeste; Irene Ward; Peter J Romanienko; Julio C Morales; Kazuhito Naka; Zhenfang Xia; R Daniel Camerini-Otero; Noboru Motoyama; Phillip B Carpenter; William M Bonner; Junjie Chen; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

8.  Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle.

Authors:  Daniel D Kaplan; Thomas E Meigs; Patrick Kelly; Patrick J Casey
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

9.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Authors:  Tewis Bouwmeester; Angela Bauch; Heinz Ruffner; Pierre-Olivier Angrand; Giovanna Bergamini; Karen Croughton; Cristina Cruciat; Dirk Eberhard; Julien Gagneur; Sonja Ghidelli; Carsten Hopf; Bettina Huhse; Raffaella Mangano; Anne-Marie Michon; Markus Schirle; Judith Schlegl; Markus Schwab; Martin A Stein; Andreas Bauer; Georg Casari; Gerard Drewes; Anne-Claude Gavin; David B Jackson; Gerard Joberty; Gitte Neubauer; Jens Rick; Bernhard Kuster; Giulio Superti-Furga
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

Review 10.  Emerging concepts in colorectal neoplasia.

Authors:  Jeremy R Jass; Vicki L J Whitehall; Joanne Young; Barbara A Leggett
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  9 in total

1.  Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue.

Authors:  Bilge Aktas; Hongxia Sun; Hui Yao; Weiwei Shi; Rebekah Hubbard; Ya Zhang; Tingting Jiang; Sophia N Ononye; Vikram B Wali; Lajos Pusztai; W Fraser Symmans; Christos Hatzis
Journal:  Mol Oncol       Date:  2014-02-17       Impact factor: 6.603

2.  'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.

Authors:  F A Benthani; D Herrmann; P N Tran; L Pangon; M C Lucas; A H Allam; N Currey; S Al-Sohaily; M Giry-Laterriere; J Warusavitarne; P Timpson; M R J Kohonen-Corish
Journal:  Oncogene       Date:  2017-10-16       Impact factor: 9.867

3.  The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up.

Authors:  Arfon G M T Powell; Jenny Ferguson; Fahd Al-Mulla; Clare Orange; Donald C McMillan; Paul G Horgan; Joanne Edwards; James J Going
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

4.  Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Authors:  Fahad Benthani; Phuong N Tran; Nicola Currey; Irvin Ng; Marc Giry-Laterriere; Louise Carey; Maija R J Kohonen-Corish; Laurent Pangon
Journal:  Int J Mol Sci       Date:  2015-05-19       Impact factor: 5.923

5.  Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms.

Authors:  Carissa R Moore; Shanique Ke Edwards; Ping Xie
Journal:  J Cancer Sci Ther       Date:  2015-02

6.  MCC Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and Olaparib.

Authors:  Zeenat Jahan; Fahad A Benthani; Nicola Currey; Hannah W Parker; Jane E Dahlstrom; C Elizabeth Caldon; Maija R J Kohonen-Corish
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

7.  Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes.

Authors:  Shanique K E Edwards; Jacqueline Baron; Carissa R Moore; Yan Liu; David H Perlman; Ronald P Hart; Ping Xie
Journal:  J Hematol Oncol       Date:  2014-09-09       Impact factor: 17.388

8.  Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.

Authors:  Nicola Currey; Zeenat Jahan; C Elizabeth Caldon; Phuong N Tran; Fahad Benthani; Penelope De Lacavalerie; Daniel L Roden; Brian S Gloss; Claudia Campos; Elaine G Bean; Amanda Bullman; Saskia Reibe-Pal; Marcel E Dinger; Mark A Febbraio; Stephen J Clarke; Jane E Dahlstrom; Maija R J Kohonen-Corish
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-02

9.  Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer.

Authors:  Sabine Meessen; Nicola Currey; Zeenat Jahan; Hannah W Parker; Mark A Jenkins; Daniel D Buchanan; John L Hopper; Eva Segelov; Jane E Dahlstrom; Maija R J Kohonen-Corish
Journal:  Cancers (Basel)       Date:  2021-07-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.